Torben Knuschke

Dr. Torben Knuschke

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 July 2013 in Acta Biomaterialia
Verified
Journal Article
Closed access
VSViktoriya Sokolova
Viktoriya Sokolova
DKDiana Kozlova
Diana Kozlova
TKTorben Knuschke
Torben Knuschke
JBJan Buer
Jan Buer
AWAstrid M. Westendorf
Astrid M. Westendorf
MEMatthias Epple
Matthias Epple

2 November 2011 in Journal of Materials Chemistry
Verified
Journal Article
Closed access
PDF file
DKDiana Kozlova
Diana Kozlova
SCSvitlana Chernousova
Svitlana Chernousova
TKTorben Knuschke
Torben Knuschke
JBJan Buer
Jan Buer
AWAstrid M. Westendorf
Astrid M. Westendorf
MEMatthias Epple
Matthias Epple
Calcium phosphate nanoparticles were coated with a shell of silica and covalently functionalized by silanization, either with thiol or with amino groups. This permits the covalent attachment of molecules like dyes or antibodies. Between the calcium phosphate surface and the outer silica shell, biomolecules like nucleic acids (DNA or siRNA) can be incorporated as cargo. This leads to cell-specific carriers of biomolecules into cells, e.g. for transfection, gene silencing or cell activation. The cellular uptake of antibody-coated calcium phosphate nanoparticles was demonstrated on two cell lines: HeLa (epithelial cell line) and MG-63 (osteoblast-like cell line). Furthermore, the functionalization of calcium phosphate nanoparticles with a dendritic cell-specific antibody (CD11c) led to a cell-specific targeting as shown with primary murine splenocytes. Thus, the successful coating of calcium phosphate nanoparticles with cell-specific antibodies makes them suitable for many clinical applications.

15 June 2013 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
TKTorben Knuschke
Torben Knuschke
VSViktoriya Sokolova
Viktoriya Sokolova
OROlga Rotan
Olga Rotan
MWMunisch Wadwa
Munisch Wadwa
MTMatthias Tenbusch
Matthias Tenbusch
AWAstrid M. Westendorf
Astrid M. Westendorf
The ability of vaccines to induce T cell responses is crucial for preventing diseases caused by viruses or bacteria. Nanoparticles (NPs) are considered an efficient tool for inducing potent immune responses. In this study, we describe a novel vaccination approach with biodegradable calcium phosphate (CaP) NPs that serve as carrier of immunoactive TLR9 ligand (CpG) combined with a viral Ag from the influenza A virus hemagglutinin. Functionalized CaP NPs were efficiently taken up by dendritic cells in vivo and elicited a potent T cell–mediated immune response in immunized mice with high numbers of IFN-γ–producing CD4+ and CD8+ effector T cells. Most importantly, both i.p. and intranasal immunization with these NPs offered protection in a mouse model of influenza virus infection. This study demonstrates the great potential of CaP NPs as a novel vaccination tool that offers substantial flexibility for several infection models.

1 November 2017 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
AFAnnika Frede
Annika Frede
BNBernhard Neuhaus
Bernhard Neuhaus
TKTorben Knuschke
Torben Knuschke
MWMunisch Wadwa
Munisch Wadwa
SKSebastian Kollenda
Sebastian Kollenda
AWAstrid M. Westendorf
Astrid M. Westendorf

1 June 2011 in Gastroenterology
Verified
Journal Article
Open access
PDF file
MRMarianne Ruhl
Marianne Ruhl
TKTorben Knuschke
Torben Knuschke
KSKevin Schewior
Kevin Schewior
LGLejla Glavinic
Lejla Glavinic
CNChristoph Neumann-Haefelin
Christoph Neumann-Haefelin
JTJörg Timm
Jörg Timm
Infections with the hepatitis C virus (HCV) are a serious public health problem worldwide. Upon acute infection with HCV, up to 80% of patients develop chronic infection with viral persistence. The differences between patients who develop chronic infection and those who are able to spontaneously control viral replication are still not fully understood. Both innate and adaptive immune responses are believed to play important roles in viral containment. In cross-sectional studies on patients with resolved or chronic infection, as well as in longitudinal studies of patients with acute infection, an important role of CD8 T cells for immune control has been highlighted.1 x 1 Rehermann, B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest. 2009; 119: 1745–1754 Crossref | PubMed | Scopus (379) | Google Scholar See all References , 2 x 2 Bowen, D.G. and Walker, C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature. 2005; 436: 946–952 Crossref | PubMed | Scopus (580) | Google Scholar See all References Interestingly, comprehensive analyses of the CD8 T-cell response during acute HCV infection demonstrated that HCV-specific CD8 T cells are activated in most patients, but that these responses are not maintained when virus persists.3 x 3 Cox, A.L., Mosbruger, T., Lauer, G.M. et al. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology. 2005; 42: 104–112 Crossref | PubMed | Scopus (175) | Google Scholar See all References These results suggest secondary failure of virus-specific CD8 T cells in chronic HCV infection. Multiple mechanisms for secondary failure of HCV-specific CD8 T cells have been described, including their exhaustion in the presence of high antigen levels by up-regulation of inhibitory receptors, such as PD-1 and CTLA-4, or suppression by regulatory T cells.4 x 4 Nakamoto, N., Cho, H., Shaked, A. et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog. 2009; 5: e1000313 Crossref | PubMed | Scopus (208) | Google Scholar See all References , 5 x 5 Radziewicz, H., Ibegbu, C.C., Fernandez, M.L. et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol. 2007; 81: 2545–2553 Crossref | PubMed | Scopus (324) | Google Scholar See all References , 6 x 6 Bengsch, B., Seigel, B., Ruhl, M. et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog. 2010; 6: e1000947 Crossref | PubMed | Scopus (209) | Google Scholar See all References